Sort
51,593 grants matching “hepatitis”
HIV, HCV, Hippo, and Liver Disease Progression
$608,551Raymond T Chung · Massachusetts General Hospital · R01 · FY2021 · AI
Quantitative MRI and Deep Learning Technologies for Classification of NAFLD
$608,300Holden H Wu · University Of California Los Angeles · U01 · FY2022 · EB
Neurobehavioral Effects of HIV & Host Genetics in China
$608,256Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2007 · MH
Yittrium-90 radiation lobectomy: Dose optimization and prediction of FLR hypertrophy to enable resection of HCC
$608,142Robert J Lewandowski · Northwestern University At Chicago · R01 · FY2025 · CA
Genetic and Metabolic Basis of Fatty Liver Disease
$608,140Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2022 · DK
Genetic and Metabolic Basis of Fatty Liver Disease
$608,140Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2019 · DK
Genetic and Metabolic Basis of Fatty Liver Disease
$608,140Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2018 · DK
Genetic and Metabolic Basis of Fatty Liver Disease
$608,140Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2020 · DK
Genetic and Metabolic Basis of Fatty Liver Disease
$608,140Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2021 · DK
ATP Binding Cassette Transporters in Health and Disease
$608,139Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2023 · DK
ATP Binding Cassette Transporters in Health and Disease
$608,139Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2021 · DK
ATP Binding Cassette Transporters in Health and Disease
$608,139Elizabeth Joanna Tarling · University Of California Los Angeles · R01 · FY2022 · DK
Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases
$608,113Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DK
Building iCRISP: Indigenous Community-Informed Research Infrastructure to address Substance Misuse and Pain Management
$608,095Cherry M. Beasley · Lumbee Land Development, Inc. · OT2 · FY2024 · DA
Optimization of Supercritical Carbon Dioxide Based Virus Inactivation, Characterized by Protein Damage and Maintenance of Epitope Integrity in Vaccine Sterilization
$608,082Julien Fey · Novasterilis, Inc. · R44 · FY2017 · AI
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids
$608,005Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2016 · DA
Role of the Macrophage in Developmentally Programmed NAFLD
$607,942Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2020 · DK
Candidate Genes Affecting Adolescent Metabolic Syndrome
$607,904Ahmed H Kissebah · Medical College Of Wisconsin · R01 · FY2007 · DK
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$607,872David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Neural Bases of Cephalic Phase Endocrine Responses
$607,797Alan C Spector · Florida State University · R01 · FY2021 · DK
Mechanisms of Altered Hepatic Transport: Impact on Drug Therapy
$607,789Kim L Brouwer · Univ Of North Carolina Chapel Hill · R35 · FY2023 · GM
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression
$607,782Raymond T Chung · Massachusetts General Hospital · R01 · FY2013 · DK
Search For New and Emerging Etiologic Agents
$607,754Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Role of FGF23 peptides in chronic kidney disease (CKD)
$607,714Nicolae Valentin David · Northwestern University At Chicago · R01 · FY2025 · DK
Pathogenesis of Liver Fluke Induced Cancer in Thailand
$607,691Paul J Brindley · Tulane University Of Louisiana · U01 · FY2006 · AI